BIOCHIPS MARKET EXPECTED TO REACH $3.840.7 MILLION BY 20013.
The market is broken down into applications of DNA microarrays, protein microarrays, emerging microarrays and lab-on-a-chip (LOAC) technologies. Of these sectors, DNA microarrays have the largest share of the market, worth an estimated $947.3 million in 2007 and expected to reach $999 million in 2007 and $1,644.2 million by 2013, a CAGR of 10.8%. The overall growth rate of DNA microarrays is slowed by the continuing maturation of the gene expression market, which represents a large segment of DNA microarrays. However, newer applications for DNA microarrays are emerging, including SNP genotyping, and are providing a significant growth impetus to this market segment. LOACs have the second largest market share, expected to reach nearly $691.3 million in 2008 and $1,245.4 million by 2013, a CAGR of 12.5%. DNA microarrays and LOACs are projected to continue to dominate the biochip market through 2013.
Protein microarrays are an emerging market opportunity as a result of continuing advances in proteomics to understand gene function and diseases. Tissue microarrays represent a growth opportunity in the emerging microarray segment.
Report published September 2007 at a print price of $4250 by BCC Research (www.bccresearch.com), 40 Washington Street, Suite 110, Wellesley, MA; Telephone: 866/285-7215,
|Printer friendly Cite/link Email Feedback|
|Publication:||Biotech Equipment Update|
|Date:||Jan 1, 2008|
|Previous Article:||DATASCOPE AIMS TO CREATE GROWTH MARKET IN PATIENT MONITORING.|
|Next Article:||AETHLON FILES PATENT ON HEMOPURIFIER USE FOR BIOMARKERS.|